An August study finds MDxhealth SA may have an effective tool in determining risk for prostate cancer with its ConfirmMDx screening. Aggressive prostate cancer (PCa) risk has historically been difficult to pinpoint, leading to false positives and unneeded treatment, as well as men who have cancer that biopsy did not detect. Read More
